SEC Comment Letter for GSK (GSK) — Mar 21, 2011

GSK plc
Date: March 21, 2011 · CIK: 0001131399 · Accession: 0000000000-11-017205

View on Edgar

AI Filing Summary & Sentiment

Date

December 31, 2009

Author

Melissa Rocha

Form

UPLOAD

Company

GSK plc

Letter

March 4 , 2011 Mr. Julian Heslop Chief Financial Officer GlaxoSmithKline plc 980 Great West Road Brentford, TW8 9GS England

Re: GlaxoSmithKline plc Form 20- F for Fiscal Year Ended December 31, 2009 File No. 001 -15170

Dear Mr. H eslop : We have completed our review of your Form 20- F and related filings and have no further comments at this time. Sincerely,

Melissa Rocha Accounting Branch Chief

Show Raw Text

March 4 , 2011
 Mr. Julian Heslop
Chief Financial Officer
GlaxoSmithKline plc
980 Great West Road
Brentford, TW8 9GS
England

Re: GlaxoSmithKline plc
  Form 20- F for Fiscal Year Ended December 31, 2009
  File No. 001 -15170

Dear  Mr. H eslop :
 We have completed our review of your Form 20- F and related filings and have no further
comments at this time.
 Sincerely,

Melissa Rocha
Accounting Branch Chief

SecProbe.io